Ciprofol's effect on low blood pressure during surgery in elderly patients on certain medications
Official title: The Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors: a Prospective, Randomized Controlled Trial
Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT06952608 · Data updated 2026-11-12
This study is testing if a new anesthetic called ciprofol can help prevent low blood pressure during surgery in older patients who have been taking certain heart medications.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | April 10, 2025 |
| Main results expected | February 10, 2026 |
| Study ends | April 10, 2026 |
| Registry record updated | December 30, 2025 |
| Trial ID | NCT06952608 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly patients aged 65 and older, undergoing elective abdominal surgery while on long-term renin-angiotensin system inhibitors.
✕Probably not a fit
Patients with severe cardiac, hepatic, or renal conditions, or those with a history of allergies to the study medications, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of ciprofol, a new intravenous anesthetic, on preventing low blood pressure during surgery in elderly patients who have been taking renin-angiotensin system inhibitors for over three months. The research focuses on patients undergoing elective abdominal surgery lasting more than two hours, assessing whether ciprofol can provide better hemodynamic stability compared to the traditional anesthetic propofol. Given the increased risk of intraoperative hypotension in this demographic, the findings could significantly influence anesthetic practices for these vulnerable patients.
Why it matters
Potential benefit: If successful, this study could lead to improved safety and outcomes for elderly patients undergoing surgery by reducing the risk of intraoperative hypotension.
How similar studies have gone: Previous studies have suggested that ciprofol may reduce intraoperative hypotension compared to propofol, but robust evidence from randomized controlled trials is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients undergoing elective abdominal surgery under general anesthesia 2. Duration of surgery exceeding 2 hours 3. Patients receiving long-term renin-angiotensin system inhibitor therapy (\>3 months prior to surgery) 4. Age ≥ 65 years 5. ASA classification II-III 6. Informed consent was obtained from patients or their guardians Exclusion Criteria: 1. History of allergy to opioids, propofol, or ciprofol components. 2. Anticipated difficult airway (limited mouth opening, restricted neck movement, or modified Mallampati grade III-IV) or difficult mask ventilation. Body mass index ≤18 or ≥35 kg/m². 3. Severe hepatic dysfunction (total bilirubin ≥3.0 mg/dL or AST/ALT ≥2 times the upper limit of normal). 4. Severe renal impairment (creatinine clearance ≤30 mL/min). 5. Cardiac diseases (AV block higher than first-degree, heart rate \<50 bpm, severe arrhythmias, severe valvular heart disease, heart failure, or unstable angina on the day of surgery). 6. Preoperative cognitive impairment, cerebrovascular disease, or history of psychiatric illness. 7. Abnormal thyroid-stimulating hormone levels or history of thyroid replacement therapy. 8. Unstable asthma or history of asthma. 9. Alcohol abuse, drug abuse, chronic opioid dependence, or analgesic use exceeding 3 months. 10. Lactating or pregnant women.
Where it's running
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Min Yan
- Email: zryanmin@zju.edu.cn
- Phone: 0571-87783759
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair
This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.
-
Remimazolam vs. Propofol for Maintaining Anesthesia During Major Liver Resection
This study tests whether remimazolam keeps blood pressure steadier than propofol during major liver surgery in adults.
-
Remimazolam versus Midazolam for anesthesia induction in older adults
This observational study compares remimazolam and midazolam when inducing anesthesia in people aged 65 and older undergoing elective non-cardiac surgery to see which provides better stability and safety.
-
Keep blood pressure at 85 or more during surgery to prevent delirium in older adults with hypertension
In older adults with high blood pressure undergoing non-heart surgery, researchers test if keeping mean arterial pressure at or above 85 mmHg during surgery reduces postoperative delirium.
-
Ciprofol and Fentanyl for LMA Insertion in Children: Finding the ED95 Dose
This study tests the smallest effective single dose of ciprofol, given with fentanyl, to help placing a laryngeal mask airway in children aged 1–12 undergoing anesthesia.
-
Internal Jugular Vein Collapsibility to Predict Hypotension in Older Adults Undergoing Laparoscopic Colorectal Surgery
This study tests whether measuring the internal jugular vein collapsibility index can predict intraoperative hypotension in patients aged 60 and older undergoing elective laparoscopic colorectal surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.